Cargando…
RNA-binding protein 39: a promising therapeutic target for cancer
RNA-binding motif protein 39 (RBM39), as a key factor in tumor-targeted mRNA and protein expression, not only plays a vital role in tumorigenesis, but also has broad development prospects in clinical treatment and drug research. Moreover, since RBM39 was identified as a target of sulfonamides, it ha...
Autores principales: | Xu, Caipeng, Chen, Xiaohua, Zhang, Xuetian, Zhao, Dapeng, Dou, Zhihui, Xie, Xiaodong, Li, Hongyan, Yang, Hongying, Li, Qiang, Zhang, Hong, Di, Cuixia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363639/ https://www.ncbi.nlm.nih.gov/pubmed/34389703 http://dx.doi.org/10.1038/s41420-021-00598-7 |
Ejemplares similares
-
Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation
por: Dou, Zhihui, et al.
Publicado: (2021) -
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
por: Chen, Xiaohua, et al.
Publicado: (2022) -
Crosstalk of the Caspase Family and Mammalian Target of Rapamycin Signaling
por: Yan, Junfang, et al.
Publicado: (2021) -
A SNP involved in alternative splicing of ABCB1 is associated with clopidogrel resistance in coronary heart disease in Chinese population
por: Zhang, Shasha, et al.
Publicado: (2020) -
CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?
por: Battastini, Ana Maria Oliveira, et al.
Publicado: (2021)